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National guidelines recommend that practitioners
assess and reinforce patient adherence when prescribing
antiretroviral (ART) medications, but the extent to which




To assess the adherence counseling practices of
physicians caring for patients with HIV/AIDS in North Carolina









All physicians in North Caro-
lina who prescribed a protease inhibitor (PI) during 1999.
Among the 589 surveys sent, 369 were returned for a response
rate of 63%. The 190 respondents who reported prescribing a




Physicians reported how often
they carried out each of 16 adherence counseling behaviors as




On average, physicians reported spending 13 min-
utes counseling patients when starting a new 3-drug ART
regimen. The vast majority performed basic but not more
extensive adherence counseling; half reported carrying out 7
or fewer of 16 adherence counseling behaviors “most” or “all
of the time.” Physicians who reported conducting more adher-
ence counseling were more likely to be infectious disease
specialists, care for more HIV-positive patients, have more time
allocated for an HIV visit, and to perceive that they had enough
time, reimbursement, skill, and office space to counsel. After
also controlling for the amount of reimbursement and avail-
ability of space for counseling, physicians who were signifi-
cantly more likely to perform a greater number of adherence
counseling practices were those who 1) cared for a greater
number of HIV/AIDS patients; 2) had more time allocated for
an HIV physical; 3) felt more adequately skilled; and 4) had




This first investigation of adherence coun-
seling practices in HIV/AIDS suggests that physicians caring
for patients with HIV/AIDS need more training and time allo-
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ational treatment guidelines for HIV/AIDS rec-
ommend that medical practitioners routinely assess,
reinforce, and support patient adherence to complex





 Physician–patient communication about









such as helping patients develop strategies to overcome




 to be out-




 Some physicians may
feel unable to effectively address adherence due to lack of
time, reimbursement, or training.
Understanding antiretroviral counseling practices of
physicians could guide the development of comprehensive
ART adherence interventions, but information about such
practices is currently limited. No studies have assessed
physicians’ adherence-related practices specific to HIV/
AIDS treatment. Previous studies have shown that phys-
icians with more experience treating patients with HIV/




 however, these studies did not
assess the provision of adherence counseling.
In the study presented here, we assessed the usual
care antiretroviral adherence counseling practices among
all identifiable physicians in the state of North Carolina
caring for patients living with HIV/AIDS, and compared
infectious disease specialists’ and generalists’ practices.
In addition, we sought to identify physicians’ demographic,
practice, and attitudinal characteristics associated with






By mail, we surveyed all physicians in North Carolina
whom we identified as caring for patients with HIV/AIDS.
We used a prescription-tracking database maintained by
a commercial vendor to identify all physicians in North
Carolina reported to have prescribed a protease inhibitor




 The vendor is a health care information
company that obtains prescribing information from phar-




We used the criteria of “having prescribed a PI” because
this was standard treatment for HIV at the time of the
study. We sent a prenotification letter to identified phys-
icians’ preferred American Medical Association mailing
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address, followed, a few days later, by a 6-page survey and
$5 cash incentive. Among those not responding initially,
we sent 2 additional full mailings and 1 reminder postcard
from February through May 2000 (including a chance to
win a $250 prize in the last mailing). The university’s




We sent the mailing to all of the 609 North Carolina
physicians whose name appeared on at least 1 prescription
transaction for a PI in 1999. Three of the physicians had
died and 17 surveys were returned due to bad addresses.
Among the remaining 589 surveys, 369 were returned for
a usable response rate of 63%.
Respondents who reported on the survey that they had
written at least 1 prescription for a PI in the last year and
that they currently cared for at least 1 HIV-positive patient
were considered eligible. Among the 357 respondents who
answered these items, 190 of these met eligibility criteria
and comprised the study sample. Based on conversations
with the vendor, we speculate that reasons for the dis-
crepancy between the number of names listed in the
prescription-tracking database and the number reporting
that they had prescribed a PI include: 1) some physicians
who had signed a prescription did not consider themselves
to be the prescribing physician (e.g., a surgeon writing post-
operative orders on an HIV-positive patient); or 2) some
physicians’ names were entered erroneously when the
prescription was dispensed, probably because of illegible
signatures.
Self-reported demographic and practice characteris-
tics of eligible respondents were compared with those of
ineligibles. As expected, ineligible respondents were more
likely to be from a specialty other than internal medicine,
family practice, or infectious diseases and from a non-
academic practice. In fact, only 1% of ineligible responders












the Adherence and Efficacy of Protease Inhibitor Therapy










 and OBRA-90 (Omnibus
Budget) guidelines, a 16-item 5-point scale (ranging from
“never” to “all of the time”) was developed by the investi-
gators (CEG, SRS, SR) to represent counseling behaviors
that physicians used “when prescribing a new antiret-
roviral regimen” (Table 2). Likewise, we also developed an
8-item 5-point scale representing 8 adherence counseling
behaviors that physicians performed “on follow-up visits
after starting antiretrovirals.” Physicians were asked, for
each of these behaviors, “Thinking of your typical practice
when prescribing anitretrovirals, please indicate how often
you do each of the following activities.” Final revisions were
made based on pilot testing of items for face validity,
content, and wording among 15 social scientists, clinicians,
and clinician researchers.
The number of behaviors conducted “most” or “all of
the time” were summed to create an overall discrete scale
of the number of adherence counseling behaviors con-
ducted “when prescribing a new antiretroviral regimen.”
We also asked physicians, “On average, how much
time, if any, do you spend counseling a patient about his
or her medication 1) when initiating a typical new 3-drug
combination of antiretrovirals?”; and 2) “during a follow-
up visit after starting a typical 3-drug regimen of antiret-
rovirals?” We chose to ask about a 3-drug regimen because




 of HIV therapy at the time of the




 To assess the
construct validity of the behavior scales, we examined
the correlation between the number of adherence counseling
behaviors reported performed, and the number of minutes
respondents reported they spent counseling; we found










Potential Predictors of Adherence Counseling and 
Covariates
 








 Zip codes of respondents’
primary practices were linked to the county-based Area





the time, space, training, and reimbursement available to
physicians for adherence counseling, adapting questions




 (see Appendix). To
assess time-related factors, we asked respondents to





 and the amount of time you feel would
be needed to provide high quality care for your HIV/AIDS
patients for: 1) a complete physical/consultation visit; and









 beliefs, and knowledge about adherence
counseling, antiretroviral medications, and HIV-positive
patients were assessed, as well as their job satisfaction as




We used North Carolina State Medical Licensure Board
data to compare the demographic and practice charac-
teristics of respondents and nonrespondents. Among the
study sample, we conducted descriptive statistics of demo-
graphic, practice, and attitudinal features. We compared
the characteristics of generalists and infectious disease










 test as appropriate.
We assessed the sample with regard to the following
outcome variables: 1) the number of minutes spent coun-
seling for a 3-drug regimen both a) when prescribing a new
regimen and b) during routine follow-up; 2) how often








behaviors (16 for prescribing a new regimen, and 8 for
routine follow-up visits) were performed; and 3) the total
number of the 16 adherence counseling behaviors per-
formed for a new prescription “most” or “all of the time.”
Although counseling during follow-up visits probably has
an important influence on patient adherence, the primary
outcome of interest in this analysis was “the number of
adherence counseling behaviors performed for a new pre-
scription.” We focused this analysis on new prescription
initiation for 2 reasons: 1) when this study was conducted,
more emphasis had been placed on recommended coun-




 and 2) counseling
behaviors conducted during prescription initiation are less
variable and therefore easier to compare than are activities
taking place during follow-up visits.
To understand the influence of time allocation on spe-
cific behaviors, we evaluated the proportion of respondents
who carried out each counseling behavior, stratified by
whether they reported having a “high” or “low” amount of
time allocated to conduct a complete HIV/AIDS patient
physical (dichotomized at 30 minutes, the median value).
Because our primary outcome variable, the number of
behaviors performed for a new prescription, was a discrete
scale, we conducted Poisson regression, using the PROC
GEN MOD procedure in SAS 8.0 (SAS Institute Inc., Cary,
NC), to assess the bivariate associations between categ-





multivariate Poisson regression was used to assess the
independent relationship between potential predictor
variables and the number of adherence counseling





 correcting for overdispersion by using




 The model was selected




 conceptualization of potential predictors
of adherence practices, incorporating variables related to




 < .10 and con-
sidering multicollinearity. Because medical specialty was
both associated with adherence practices and highly cor-
related with many variables in the model, it was excluded
from the model; to assess the effect of HIV/AIDS care
experience, we included HIV patient volume instead.
This research was funded in its entirety by a 1999
developmental grant from the University of North Carolina
at Chapel Hill Center for AIDS Research (CFAR), an NIH-
funded program, #9P30 AI50410. Dr. Golin’s salary was
supported in part by NIH grant #5-K23-MH0186.
 
RESULTS
Demographic and Practice Characteristics 
of the Sample
 
Twenty-five percent of physicians in the sample were
ID specialists, with 37% general internists, 28% family prac-
titioners, and 10% other specialties (Table 1). A minority
(36%) practiced in an academic institution. Over half cared
for fewer than 10 HIV-positive patients; 25% cared for 3 or
fewer. Respondents were more likely than nonrespondents
to be male, internists or family practitioners, and from a
large, nonacademic group.
 
Health System Characteristics and Physician 
Attitudes, Beliefs, and Knowledge
 
The majority (97% to 99%) of physicians viewed adher-
ence counseling as their role and had positive attitudes
toward both ART and HIV/AIDS patients. However, nearly
half felt that they did not have enough time; only 10% felt
adequately reimbursed; about half felt inadequately skilled;
and over 25% did not have enough space to provide adher-
ence counseling. On average, physicians reported having
38 minutes allocated (median 30 minutes) to carry out a
complete history and physical for a patient with HIV/AIDS,




Number of Minutes Spent.
 
On average, for a 3-drug regimen,
physicians reported spending 13 minutes (SD [standard
deviation] 9.4, median 10, range 0 to 60) counseling patients
initiating therapy and 7.5 minutes (SD 7, median 5.0,
range 0 to 60) counseling them during a follow-up visit.
 
Adherence Counseling Behaviors Performed.
 
The vast
majority (92% to 94%) of physicians reported providing
basic dosing instructions “most” or “all of the time,” but a
minority reported helping patients plan dose times, explain
what to do if a dose was missed, suggest ways to remember
doses, or ask the patient to repeat dosing instructions.
A substantial minority did not explain drug interactions,
tailor the regimen to the patient, or give advice about side
effect management.
Half of physicians reported routinely carrying out 7
or fewer of the 16 adherence counseling behaviors.
 
Relationship Between Adherence Counseling 
Practices and Amount of Time Allocated
 
In stratified analyses, practitioners who reported a
greater amount of time allocated (over 30 minutes) to conduct
a complete physical spent significantly more time counseling




 = .02), but those allocated more time for a follow-up visit
did not spend more time counseling in a follow-up visit.
Practitioners who had more time allocated were also
more likely to carry out a greater number of the counseling
behaviors for a new but not for a continuing prescription.
For continuing prescriptions, practitioners who had more
time allocated to conduct a follow-up visit were less likely
to ask a case manager to counsel patients about adherence
(Table 2).
 
Characteristics of Generalists Compared with 
Infectious Disease Specialists
 
Not surprisingly, among the sample, infectious disease








HIV/AIDS (Table 3). Infectious disease doctors felt they
needed, spent, and had allocated more time to provide high-
quality care than did generalists. More generalists had time
stress (i.e., needed more time than was allocated) than did
infectious disease specialists, yet similar proportions felt
that they did not have enough time to conduct adherence




 = .13). Although infectious dis-
ease specialists reported spending no more time counseling
their patients about ART adherence, they did report per-
forming significantly more adherence counseling behaviors




 < .0001). Although
a greater proportion of infectious disease doctors felt
adequately skilled to counsel about adherence, they did not
differ from others regarding job satisfaction, attitudes toward
HIV-positive patients, beliefs about their role, or attitudes
regarding reimbursement for adherence counseling.
Of note, although we did not have adequate numbers
of respondents to compare across all specialities, quali-
tatively, we found that internists and family practitioners
performed similar counseling activities.
 
Additional Bivariate Associations Between 
Physician Characteristics and Adherence 
Counseling Practices
 
In bivariate analyses, physicians who reported carry-
ing out more adherence counseling were not only more
likely to be infectious disease specialists, but also cared for
more HIV-positive patients, had more time allocated to
see HIV-positive patients, and perceived that they had enough
time, office space, reimbursement, and skill to do adher-
ence counseling (Table 4). Practitioners who agreed that
Table 1. Characteristics of North Carolina Physicians Caring for Patients with HIV
Did Prescribe a Protease Inhibitor (Study Sample) N = 190
Demographic Factors













Year graduated MD, mean 1985
Board certified, % 79
Practice Characteristics
Type of practice, %
Solo 10
Small group (2 to 9 MDs) 34
Large (single or multispecialty) group 14
Large single specialty group (10 + MDs) 5
Large multispecialty group (10 + MDs) 9
Group/staff model HMO 1
Academic group practice 36
Other 5
Rural practice, % 23
Number of HIV-positive patients currently care for, mean number patients (median, range) 59 (10, 0 to 1200)
Health System Factors
Time allocated for HIV physical, mean number minutes (median, range) 38 (30, 10 to 120)
Time needed for HIV physical, mean number minutes (range) 53 (10 to 120)
I don’t have enough time, % agree or strongly agree 46
I am adequately reimbursed, % agree or strongly agree 10
I am adequately skilled, % agree or strongly agree 54
I do not have enough space, % agree or strongly agree 28
Physician Attitudes/Belief/Knowledge
Adherence counseling is not physician’s role, % agree or strongly agree 1
ART is too much trouble, % agree or strongly agree 3
Negative attitudes toward patients with HIV, mean on a scale of 1 to 5 (range) 1.67 (1.0 to 4.2)
Knowledge that nonadherence can cause resistance, % agree or strongly agree 98
Seen USPHS/IDSA Guidelines, % yes 76








Table 2. Proportion of Physicians Performing Adherence Counseling Activities Among All Physicians, Comparing Those with 
 










Some of the 
Time, %














Tailor the antiretroviral prescription to patient’s daily 
routine.
Low time allocated 107 18 28 54
High time allocated 73 7 14 79 10.9 .0010
Explain the dosing schedule for each prescribed 
medication.
Low time allocated 107 4 6 90
High time allocated 72 0 1 98 5.4 .0200
Explain the p.o. intake requirements of the regimen.
Low time allocated 90 13 0 87
High time allocated 70 4 0 95 10.6 .052
Explain potential drug interactions.
Low time allocated 105 11 27 62
High time allocated 73 5 22 73 2.8 .0945
Ask patient to repeat or rehearse dosing instructions.
Low time allocated 105 36 34 30
High time allocated 73 20 36 44 5.9 .0149
Help patient plan dosing times to fit his or her daily 
routine.
Low time allocated 106 36 34 30
High time allocated 73 15 25 60 16.5 .0001
Discuss resistance or other consequences of non-
adherence.
Low time allocated 103 5 6 89
High time allocated 73 0 3 97 4.7 .0305
Provide written dosing instructions.
Low time allocated 104 16 21 63
High time allocated 73 12 22 66 0.41 .5196
Suggest strategies to remember when to take 
antiretrovirals.
Low time allocated 105 39 30 30
High time allocated 73 12 39 40 13.6 .0002
Advise patients about ways to manage ART side 
effects.
Low time allocated 107 19 33 49
High time allocated 73 7 21 73 10.6 .0012
Explain what to do if a dose is missed.
Low time allocated 105 38 29 33
High time allocated 73 12 33 55 14.1 .0002
Provide a pill box or pill organizer with compartments.
Low time allocated 105 62 24 14
High time allocated 73 41 32 27 8.7 .0032
Ask if patient has questions or concerns about their 
treatment.
Low time allocated 105 2 7 91
High time allocated 73 0 4 96 1.8 .1763
Ask a nurse to counsel a patient about adherence.
Low time allocated 105 64 14 22
High time allocated 72 60 14 26 0.43 .5077
Ask a pharmacist to counsel a patient about adherence.
Low time allocated 103 62 14 24
High time allocated 73 69 14 18 1.03 .3099
Phone patient to follow up on antiretroviral use or side 
effects.
Low time allocated 103 67 22 11
High time allocated 71 63 27 10 0.07 .7890
Refill prescriptions
Ask whether the patient experienced side-effects.
Low time allocated 116 0 8 92














Asked whether antiretrovirals were being taken on time.
Low time allocated 116 5 12 83
High time allocated 62 7 7 87 0.08 .7760
Reviewed dosing instruction for the regimen with the 
patient.
Low time allocated 115 8 19 73
High time allocated 61 3 18 79 1.21 .2710
Ask about barriers that make it hard to take 
antiretrovirals.
Low time allocated 115 16 36 49
High time allocated 61 10 26 64 3.42 .0643
Warn patient you would 
stop therapy if antiretrovirals were
not taken as prescribed.
Low time allocated 113 29 24 47
High time allocated 61 34 25 41 0.66 .4162
Ask a nurse to counsel 
at follow-up.
Low time allocated 113 69 14 17
High time allocated 61 64 16 20 0.32 .5714
Ask a pharmacist to 
counsel at follow-up.
Low time allocated 115 70 15 16
High time allocated 61 67 20 27 0.00 .9874
Ask a case manager 
to counsel.
Low time allocated 111 72 16 12
High time allocated 60 53 20 27 7.5 .0063
*
 




 Cochran-Mantel Haenszel statistic, comparing physicians with low time allocated and physicians with high time allocated.






Some of the 
Time, %















antiretroviral therapy was “too much trouble for patients”
reported counseling about adherence less than those
who disagreed. Physicians who reported seeing the USPHS
guidelines for initiating ART reported carrying out more
adherence counseling.
 
Multivariate Results: Factors Independently 
Associated with the Number of Adherence 
Counseling Practices Carried Out When 
Prescribing a New Regimen
 
In the final multivariate model, physicians who were
significantly more likely to perform a greater number of
adherence counseling practices were those who 1) cared
for greater numbers of HIV/AIDS patients; 2) had more
time allocated for an HIV physical; 3) felt more adequately





National practice guidelines now recommend that





 The findings from this first statewide investi-
gation of physicians’ ART adherence counseling practices
suggest that many patients living with HIV/AIDS may not
be receiving these recommended services from their phys-
icians. Not only did physicians report not counseling their
HIV-positive patients comprehensively about ART adherence,
but also, large proportions felt that they had inadequate skill,
reimbursement, space, or time to conduct adherence coun-
seling, all factors associated with counseling less. Half of our
sample cared for relatively small numbers of patients with HIV.
These findings suggest important targets to improve
care. The physician’s role in caring for patients with chronic





studies indicate that many physicians perceive that they





being asked to take on more responsibility for facilitating
behavior change among growing numbers of patients




 Our finding that the more
time allocated, the more comprehensive is the physician’s
counseling indicates that medical directors may need to
allot more time for comprehensive visits, particularly to treat
patients with HIV/AIDS. Although physician time is expens-
ive, the benefits of potentially slowing the emergence of
widespread drug-resistant virus may outweigh this cost




 The finding that many physicians












































Mean or % (SD) Median (range)
 
Demographics and Practice
Male, % 40 80 117 72 .31
Mean age, y 40 44 (7.9) 44 (31 to 59) 117 41 (7.3) 41 (28 to 69) .04





Rural practice, % 40 5 118 23 .012




 (mean) 40 176 (210) 135 (15 to 1200) 116 17 (25.6) 6.0 (0 to 150) < .0001
Clinical Practices
For a new regimen
Time spent counseling, minutes (mean) 39 12.4 (5.9) 10.0 (3 to 30) 107 13.2 (10.9) 10.0 (0 to 60) .56
Number of adherence counseling behaviors (mean) 40 10.2 (2.43) 11 (6 to 14) 115 7.6 (3.56) 8.0 (0 to 15) < .0001
During a follow-up visit
Time spent counseling, minutes (mean) 39 7.3 (5.5) 5.0 (1 to 30) 107 7.3 (7.4) 5.0 (0 to 60) .98
Number of adherence counseling behaviors 40 4.13 (1.52) 4 (1 to 8) 115 3.78 (1.79) 4.0 (0 to 8) .24
For a complete HIV physical
Time allocated, minutes (mean) 40 49.6 (16.0) 52.5 (20 to 90) 111 34.8 (15.7) 30.0 (10 to 120) < .0001
Time spent, minutes (mean) 40 55.9 (180) 60 (30 to 90) 110 43.1 (16.4) 45.0 (10 to 20) < .0001
Time needed, minutes (mean) 40 61 (21.6) 60 (30 to 120) 110 51.5 (18.3) 45 (10 to 120) .0085
For routine HIV follow-up
Time allocated, minutes (mean) 40 20.25 (6.4) 17.5 (15 to 30) 110 17.7 (7.11) 15.0 (5.0 to 60.0) .049
Time spent, minutes (mean) 40 23.5 (8.4) 20.0 (7.5 to 45) 108 22.3 (7.6) 20.0 (10 to 60) .42
Time needed, minutes (mean) 40 26.5 (9.7) 30.0 (15 to 45) 108 26.16 (10.3) 30.0 (10 to 60) .85
Health System Factors
I don’t have enough time, % agree or strongly agree 39 41 115 49 .13
I am adequately reimbursed, % agree or strongly agree 38 0 115 13 .21
I am adequately skilled, % agree or strongly agree 40 78 114 47 < .0003
I do not have enough space, % agree or strongly agree 38 32 113 28 .54
Job satisfaction, % very satisfied 39 59 115 50 .35
Physician Attitudes/Belief/Knowledge
Not physician’s role, % agree or strongly agree 39 3 113 0 .23
ART is too much trouble, % agree or strongly agree 39 3 114 4 .14
Knowledge that nonadherence can cause resistance, % 40 98 114 99 .63
agree or strongly agree
Seen USPHS/IDSA guidelines, % saying yes 40 100 113 69 < .0001
Negative attitudes toward HIV-positive patients 40 1.63 114 1.68 (0.59) .65
















































































Group/staff model HMO 0.646 .55
Small group (2 to 9 MD) 0.738 .08








Rural practice 1.05 .77




 = .29 < .0001
Health Care System Barriers
Minutes allocated for complete HIV physical
High
Low
I don’t have enough time









I am adequately reimbursed









I am adequately skilled









I do not have enough space










Very satisfied 0.503 .22
Moderately satisfied 0.293 .03
Neither satisfied nor unsatisfied 0.324 .16
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Physician Attitudes/Belief/Knowledge
Not physician’s role





Negative beliefs of patients r = −.14 .06
ART is too much trouble




Strongly agree 1.23 .26
Knowledge: nonadherence can cause resistance








* Based on results of Poisson regression.
† Reference category.
Risk Ratio* or Correlation Coefficient P Value
Table 4. (Continued)
is consistent both with prior studies demonstrating phys-
icians’ limited abilities to assess nonadherence54 and with
the limited training that physicians receive in health
behavior change techniques.47,48 To meet their evolving
role successfully as practitioners, continuing education
and training in the required skills are needed.29
It was somewhat surprising to find that financial reim-
bursement was unrelated to physicians’ performance of
adherence counseling, because other physician behaviors
have been linked to economic incentives in prior studies.55,56
However, we may have missed a true link between coun-
seling and reimbursement because the perceived insuf-
ficiency of reimbursement was so uniform: 90% of
physicians agreed that they were not adequately reim-
bursed for adherence counseling.
Finally, the questions of how best to allocate resources
and responsibilities to enhance patients’ antiretroviral
medication adherence, particularly in rural states, warrant
further study. Patients who better understand their ART
regimen are more adherent.57 Because HIV treatment is
medically complex,3 physicians are in a unique position to
initially inform and counsel patients about their regimen.
However, consistent with prior studies showing an associ-
ation between greater HIV caseload and better care,27–31 we
found that physicians caring for fewer HIV-positive patients
reported providing less comprehensive adherence coun-
seling. These results, coupled with our finding that most
physicians caring for patients with HIV in North Carolina
were generalists, most of whom care for fewer than 10 HIV-
infected patients, has important implications. More exten-
sive, tailored programs may be needed to augment current
continuing medical education about ART for low-volume
providers.29,58–62 Additionally, a multidisciplinary system of
care that integrates the skills of nurses, case managers,
and pharmacists with those of physicians may provide the
most cost-effective, high-quality services.58
The findings of this study must be interpreted in light
of its limitations. Because this is a cross-sectional survey,
the endogeneity inherent in the associations found limits
the ability to provide strong evidence of a causal relation-
ship. For example, although we assume that physicians’
positive attitudes and confidence in their skills may
enhance their behavior, it is possible that physicians who
counsel patients more comprehensively will feel more suf-
ficiently skilled and have more positive attitudes toward
ART as a result. Second, measurement error in the form
of recall or social desirability bias may have reduced the
validity of the self-reported adherence counseling meas-
ures. Although we confirmed the construct validity of these
measures and the correlation with physician experience
is consistent with expected group differences, we could not
assess observed physician behavior. Further, the self-
report measure we used to assess the amount of time
physicians spent counseling is subject to the same biases.
However, measurement bias would likely have over-
estimated our outcome, implying that adherence coun-
seling may be even less comprehensive than our results
indicate. In addition, understanding physicians’ per-
ceptions of and attitudes toward adherence counseling is
important and can only be obtained through self-report.
Third, our North Carolina sample may not represent all
physicians in the United States caring for patients with HIV/
JGIM Volume 19, January 2004 25
AIDS, and consequently our findings may not generalize
to others. Furthermore, our response rate of 63% is slightly
better than the average rate for mailed physician surveys,63
but physicians who were interested in adherence coun-
seling were probably more likely to respond to this survey.
If so, this bias would lead us to underestimate the sub-
optimal nature of adherence counseling. Finally, although
a previously validated method was used to identify the
sample,32 the use of a commercial prescription-tracking
database resulted in sending surveys to 167 physicians
who did not provide ongoing care to patients with HIV/
AIDS. We eliminated those who were ineligible by asking
all respondents whether they had prescribed a protease
inhibitor (PI) in the last year, but we may have missed some
eligible physicians, probably those who cared for fewer
patients with HIV. We speculate that this might occur
either because they did not prescribe a PI for their HIV-
positive patients or because their medical partner’s name
was included in the tracking database in place of theirs.
Therefore, our sample may underrepresent physicians who
have smaller HIV caseloads.
Despite these limitations, this first comprehensive
description of physicians’ reports of their adherence
counseling practices suggests that the growing pressure
that physicians experience to “do more in less time” may
reach a limit, unless addressed by providing practitioners
with additional time, training, and/or resources to counsel
their patients about adherence.
The authors acknowledge the helpful comments of Thomas R.
Konrad, PhD and Andrew Kaplan, MD. We also thank Dr. Hsiao-
Chuan Tien in the Biostatistics Core of the UNC Center for AIDS
Research (CFAR), an NIH-funded program #9P30 AI 50410–04,
for her helpful consultation.
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APPENDIX




Please estimate the average time (in minutes) allocated to you, actually spent, and the amount of time you feel would be needed 
to provide high-quality care for your HIV/AIDS patients for a complete physical/consultation for: 1) a complete physical/
consultation visit; and 2) a routine follow-up visit.36
Please indicate how strongly you agree or disagree with the following statements about your HIV/AIDS patients (response options: 
strongly disagree, disagree, neutral, agree, strongly agree):
Health System Barriers
1) I do not have enough time to provide adherence counseling
2) I am adequately skilled to provide adherence counseling
3) I am adequately reimbursed for providing adherence counseling
4) There is not enough space in my clinic or office to provide adherence counseling.
Attitudes,37 Beliefs, and Knowledge
1) Taking combination therapy is too much trouble for what my patients get out of it.
2) It is not a physician’s role to counsel patients about adherence.
3) It is harder for me to feel as much empathy for my HIV/AIDS patients than for my other patients.
4) If given a choice, I would prefer not to treat patients who have substance abuse problems.
5) If given a choice, I would prefer not to treat patients who are receiving public assistance.
6) I am concerned that working with HIV/AIDS patients endangers my personal health.
7) If given a choice, I would prefer not to treat gay men.
Provider Knowledge of HIV
1) If patients do not take their antiretrovirals as prescribed, drug resistance will develop.
Provider Knowledge of HIV
1) Have you seen the U.S. Public Health Service or Infectious Disease Society of America guidelines for HIV treatment? (response 
options: yes, no, unsure)
Provider Job Satisfaction
How satisfied are you with your work as a physician?36
(Very satisfied, moderately satisfied, neither satisfied nor unsatisfied, moderately unsatisfied, very unsatisfied)
